MedTrace Logo

Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.

NCT00394680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2011-05-27

No results posted yet for this study

Summary

Options for coronary revascularization include stent implantation and coronary bypass surgery. Both modalities have their unique advantages and disadvantages in terms of clinical outcomes as well as financial impact on the medical system. We wish to investigate the late results of patients undergoing coronary revascularization, the need for re-hospitalization, re-intervention, patient satisfaction as well as the financial burden on the medical system. The study will be conducted by historical prospective review of hospital records in conjunction with records of the medical insurance companies ("HMO's").

Conditions

Sponsors & Collaborators

  • Hebrew University of Jerusalem

    collaborator OTHER

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Amir Shmueli, PhD · The Hebrew University, School of Public Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Completion
2007-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394680 on ClinicalTrials.gov